Switch Therapeutics Inc

Website
241 E Harris Ave
South San Francisco, CA 94080
https://www.switchthera.com

Switch Therapeutics Inc, located in South San Francisco, is an emerging biotechnology company focused on pioneering innovative RNA interference (RNAi) medicines aimed at treating a range of central nervous system (CNS) diseases. Utilizing their proprietary Conditionally Activated siRNA (CASi) platform, they are developing biomarker-gated genetic therapies that enhance targeting and delivery, promising to address significant unmet medical needs in the CNS field.

The CASi platform uniquely integrates properties of single and double-stranded RNA, facilitating efficient self-delivery and durable knockdown of targets within specific cell types. By enabling selective activation and expanding therapeutic windows for various diseases, Switch Therapeutics is positioned to revolutionize treatment options for patients facing debilitating CNS conditions.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Alumis Inc

Alumis provides precision medicines. They transform the lives of patients with autoimmune diseases. They bring a proven track record in precision drug development of groundbreaking therapies. They rewrite the autoimmune treatment playbook with a unique precision analytics platform to advancing their understanding of immunologic diseases. They build a pipeline of therapeutics based on genetically validated targets for application in the treatment of multiple autoimmune disease indications.

DC3 Therapeutics LLC

DC3 Therapeutics LLC, based in South San Francisco, is a contract research organization (CRO) established by scientists to provide comprehensive solutions for all stages of discovery and pre-clinical drug development. The company specializes in delivering high-quality, timely data and operates as a collaborative partner that extends the capabilities of biotech and pharma clients' internal R&D teams. Offering a wide range of services, including biomarker assays, preclinical development, and IND enablement, DC3 Therapeutics emphasizes transparency and proactive communication throughout project execution. With a strong focus on customized solutions and a proven track record, the company strives to accelerate drug development and enhance decision-making in the research process. Generated from the website

Alios Biopharma

Alios Biopharma is a biopharmaceutical company based in South San Francisco, CA, dedicated to developing innovative treatments for various medical conditions. Specializing in research and development, Alios Biopharma focuses on creating new therapies to address unmet medical needs and improve patient outcomes. Generated from their business information
United States›California›South San Francisco›Switch Therapeutics Inc

Partial Data by Infogroup (c) 2024. All rights reserved.